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We isolated Candida dubliniensis from a nonhuman 
source, namely, tick samples from an Irish seabird colony. 
The species was unambiguously identifi ed by phenotypic 
and genotypic means. Analysis of the 5.8S rRNA gene 
showed that the environmental isolates belong to C. dubli-
niensis genotype 1.
The ever-increasing number of immunosuppressed hu-mans has led to a marked rise in opportunistic infec-
tions, particularly those caused by fungi (1). Candida al-
bicans is the yeast species most commonly associated with 
oropharyngeal and systemic candidiasis in immunocom-
promised persons. However, the last 2 decades have seen 
an increase in infections by other Candida species, includ-
ing C. dubliniensis, which was fi rst recognized as distinct 
from C. albicans in 1995 in Ireland (2,3). C. dubliniensis 
has been recovered mainly from the oral cavities of HIV-
infected persons (4) but also from lungs, vaginas, blood, 
and feces; occasionally this organism causes fatal systemic 
infections (5). Isolates are assigned to 4 genotypes, defi ned 
by the sequence of the internal transcribed spacer regions 
of the rRNA gene (6).
C. dubliniensis is globally distributed. In HIV-infected 
patients, the oral prevalence is 1.5%–32% (5). In healthy 
persons not infected with HIV, C. dubliniensis is absent 
or rare, but 14% of healthy Caucasians had oral C. dubli-
niensis in a South African study (7). Like C. albicans, C. 
dubliniensis may be a member of the normal oral micro-
bial fl ora of humans, and oral candidosis may result from 
overgrowth of resident strains. In contrast to other Candida 
species, some of which are associated with birds (8,9), C. 
dubliniensis has not been found to date in nonhuman envi-
ronmental sources. This has led to speculation that the spe-
cies may be restricted to humans, possibly occupying sites 
deep within the oropharynx or upper respiratory tract (5).
The Study
Fungal strains were obtained from Ixodes uriae ticks 
(as part of a National Environment Research Council–
funded study of a tickborne virus) at a seabird breeding 
colony on Great Saltee Island, Ireland (52°07′N, 6°36′W). 
The ticks were taken from cracks in cliffs used by com-
mon guillemots (Uria aalge). Tissue cultures of tick ho-
mogenates undertaken for virus isolation were occasionally 
contaminated with yeastlike fungi.
To investigate this, individual adult ticks were homog-
enized in 1 mL minimum essential medium (MEM). Af-
ter centrifugation (30 s, 10,000× g), 0.2 mL of supernatant 
was added to 4 mL MEM, 5% fetal bovine serum, and 100 
μg/mL penicillin-streptomycin. Cultures incubated at 37°C 
were examined microscopically daily for up to 6 days. Pos-
itive cultures were plated twice on Sabouraud dextrose agar 
(SAB) with chloramphenicol (bioMérieux, Marcy l’Etoile, 
France) before phenotypic testing. Isolates were identifi ed 
by using API identifi cation kits (bioMérieux) and by con-
ventional methods (10). Antifungal drug susceptibility was 
tested according to the Clinical Laboratory Standards Insti-
tute guidelines (11). The control strains were C. albicans 
ATCC 90028, C. glabrata ATCC 90030, C. krusei ATCC 
6258, and C. dubliniensis NCPF 3949.
Internal transcribed spacer 1 and 2 regions (ITS1/
ITS2) and the 5.8S rRNA gene were amplifi ed with prim-
ers ITS1 and ITS4, described by White et al. (12). Tem-
plate DNA was prepared by boiling single SAB-grown 
colonies in 50 μL ultrapure water for 10 min. After cen-
trifugation (5 min 10,000× g), 15 μL supernatant was add-
ed to 50 μL PCRs containing 1× reaction buffer, 1 μmol/L 
ITS primers, 1.5 mmol/L MgCl2, 400 μmol/L deoxynu-
cleoside triphosphates, and 2.5 U Immolase (BiolineLtd, 
London, England, UK). Cycling parameters were 7 min 
at 95°C, 30 cycles of 1 min at 95°C, 1 min at 58°C, 1 min 
at 72°C, and a fi nal extension of 5 min at 72°C. Products 
were purifi ed (QiaQuick kit, QIAGEN Ltd., West Sussex, 
England, UK) and sequenced (BigDye kit and ABI 377 
sequencer; Applied Biosystems, Foster City, CA, USA) 
by using the ITS primers. Sequences were assembled by 
using Lasergene 6, Seqman version II, and aligned by us-
ing BioEdit software (13).
Fungal isolation was undertaken on 2 separate days 
with samples from 2 distinct sites on the island (Table 1). 
On both days, Happy Hole West (HHW) ticks were pro-
cessed immediately after Labour in Vain (LIV) ticks in the 
same class II microbiologic cabinet. No fungi were detect-
ed in HHW ticks, whereas 16.7%–27.6% of ticks sampled 
from 2 locations within LIV gave positive cultures (Table 
1). Twenty-two isolates were obtained (Table 1); SL370–
429 were from LIV-1 and SL495–531 from LIV-2 (SL = 
Saltee).
On SAB the colonies from positive cultures were a 
creamy white color with a glabrous appearance similar 
to C. albicans. SL375 had a mixed phenotype (large and 
small colonies, designated SL375–1 and SL375–2). Like 
C. albicans, all SL isolates were germ-tube positive and 
produced chlamydospores at 37°C on Corn Meal Tween 80 
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agar (Oxoid Ltd, Basingstoke, England, UK) and Czapek 
Dox (1%) Tween 80 agar (Oxoid) (Figure 1A). None of 
the SL isolates grew at 43°C on SAB (Figure 1B), which 
suggested that they might be C. dubliniensis (14). This was 
confi rmed by carbohydrate assimilation tests (Table 2) and 
by sequencing the 5.8S rRNA gene (Figure 2). With the 
API 20C AUX kit, all SL isolates yielded the same pro-
fi le at 48 h, interpreted as 99.9% C. dubliniensis (Table 2). 
Eleven isolates from LIV-1 and the C. dubliniensis (NCPF 
3949) reference strain were also tested with API 32C. All 
had an identical profi le (7143100015), interpreted as 81.9% 
C. dubliniensis and 16.9% C. albicans.
ITS sequences of isolates SL375, SL397, SL407, 
SL410, SL411, SL417, and SL422 were identical to that of 
C. dubliniensis CD33 genotype 1 (Figure 2). Nevertheless, 
phenotypic variation among the SL isolate was evident. In 
addition to variation in trehalose assimilation rates, 3–4 
distinct types were apparent in the germ tube test. Three 
independent inoculations (105 CFU/mL, mid log growth 
phase) of each isolate gave consistent morphologic differ-
Table 1. Male and female ticks positive for fungi in culture* 
No. positive/no. examined
Site Male Female Both sexes
Happy Hole West (HHW)–1 0/26 0/25 0/51
HHW-2 0/17 0/23 0/40
Labour in Vain (LIV)–1 5/30 8/29 13/59†
LIV-2 5/23 4/20 9/43‡
*Adult Ixodes uriae ticks were collected from within 2 guillemot-breeding colonies on Great Saltee on August 25, 2004. The ticks were stored frozen and 
processed by M.A.N on November 11, 2005. (HHW-1 and LIV-1) and 20. 07.06 (HHW-2 and LIV-2). 
†Isolates SL370, SL371, SL375, SL387, SL397, SL407, SL410, SL411, SL413, SL414, SL417, SL422, and SL429. 
‡Isolates SL495, SL497, SL500, SL501, SL509, SL510, SL522, SL529, and SL531. 
Figure 1. Phenotypic characteristics of environmental Candida 
dubliniensis isolates and reference strain of C. albicans. 
A) Morphology of pseudohyphal terminal chlamydospores of C. 
albicans (ATCC90028) and C. dubliniensis SL370 grown at 37°C 
on Corn Meal Tween 80 agar. Magnifi cation × 50. B) Growth of 
representative Great Saltee (SL) isolates on Sabouraud agar after 
48 h of incubation at 37°C and 43°C. The growth of the following 
isolates is shown: C. albicans (ATCC90028), C. dubliniensis 
(NCPF3949), and C. dubliniensis SL370, SL397, SL407, and 
SL410 (clockwise from the top in each petri dish).
Table 2. Substrate assimilation by Great Saltee fungi and 
Candida albicans 
API 20C AUX assimilation  
profile code* 
Substrate SL407
C. albicans
(ATCC90028)
Pentoses
 L-arabinose – –
 D-xylose – +
Hexoses
 D-glucose + +
 D-galactose + +
α-methyl-D-glucoside – +
Disaccharides
 D-cellobiose – –
  D-lactose – –
  D-maltose + +
 D-saccharose + +
 D-trehalose† – +
Trisaccharides
  D-melezitose – –
 D-raffinose – –
Alcohols
 Glycerol + –
 Adonitol + +
 Xylitol + +
 Inositol – –
  D-sorbitol + +
Organic acids 
 2-keto-gluconate + +
Amino acids 
 N-acetylglucosamine + +
Identification C. dubliniensis C. albicans 
API 20C AUX profile code 6172134 2566174
Predictive value 99.9%, excellent 99.2%,
very good
*Results for 48 hours are shown. All 22 Great Saltee isolates gave similar 
profiles. 
†By 72 hours all Saltee isolates showed some assimilation of trehalose; 
the degree of assimilation varied between isolates. 
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ences. One group produced very long germ tubes (SL375–
1, SL422, SL417 SL387, SL397, and SL413); another, me-
dium size (SL411, SL407); a third, mainly long germ tubes 
with cells that aggregate like C. parapsilosis (SL375–2 and 
SL410); and the last, elongated cigarlike cells that clamped 
together with few germ tubes (SL370 and SL371).
To determine whether C. dubliniensis was present on 
their outer surface LIV-2 and HHW-2 ticks (n = 102) were 
individually washed in 1 mL MEM before homogenization. 
C. dubliniensis was cultured from the wash supernatants of 
8 of 9 ticks that proved positive after homogenization but 
not from any of the negative ticks. These fi ndings strongly 
suggest that the fungus is present in particles adhering to 
the ticks.
The SL isolates (n = 11) were extremely sensitive to 
antifungals. MIC90s (μg/mL) were as follows: ampho-
tericin B 0.031 (Sigma-Aldrich, Saint Louis, MO, USA), 
fl ucytosine 0.031 (Valeant Pharmaceuticals International, 
Aliso Viejo, CA, USA), fl uconazole 0.125 (Pfi zer Inc., 
Sandwhich, Kent, England, UK), itraconazole 0.007 (Ortho 
Biotech, Bridgewater, NJ, USA), voriconazole 0.007 (Pfi z-
er), posaconazole 0.007 (Schering-Plough, Kenilworth, NJ, 
USA), ketoconazole <0.007 (Ortho Biotech), and caspo-
fungin <0.007 (Merck & Co., Inc., Rahway, NJ, USA).
Conclusions
Our serendipitous isolation of C. dubliniensis from the 
environment ends speculation (5) that the species might 
be confi ned to humans. Because ticks were collected from 
cracks fi lled with guillemot guano and the fungal isolates 
were associated with the surface of ticks, the most likely 
source of the fungus is bird excrement. Thus, like C. albi-
cans (8), C. dubliniensis may inhabit the digestive tract of 
marine birds. Only C. dubliniensis was isolated from the 
Great Saltee ticks; however, we have detected other Can-
dida spp. from both soil and tick samples (unpub. data) at 
other seabird colonies, which suggests that marine as well 
as terrestrial birds (9) carry a variety of yeast species (15).
The environmental isolates are members of human C. 
dubliniensis genotype 1, commonly associated with HIV 
patients (6). Sequencing of the genotype 1 CD36 isolated 
from an HIV patient is nearly complete (www.sanger.ac.uk/
sequencing/Candida/dubliniensis). Phylogenetic com- 
parison of variable loci from environmental and human 
genotype 1 isolates could be used to estimate when they 
last shared a common ancestor and thus how often C. dub-
liniensis is transmitted from the environment to humans.
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